Applied Molecular Transport announced the appointment of Shawn Cross as the company's chief financial officer and the promotion of Bittoo Kanwar, M.D. to chief medical officer. Mr. Cross, an industry veteran with operational and investment banking experience, is the company's first CFO and will lead the company's finance strategy and oversee financial operations. As chief medical officer, Dr. Kanwar who joined AMT in 2019 as SVP, Clinical Development will continue to lead clinical development activities and oversee the clinical program for AMT-101.

Shawn Cross brings over 20 years of biopharmaceutical strategic advisory and capital market experience to AMT. Prior to this appointment, Mr. Cross was at JMP Securities where he served as managing director and co-head of healthcare investment banking.